salicylamide has been researched along with 16,16-dimethylprostaglandin f2alpha in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke, MD; Falzon, M; Milton, AS | 1 |
1 other study(ies) available for salicylamide and 16,16-dimethylprostaglandin f2alpha
Article | Year |
---|---|
Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzymes due
Topics: Animals; Anti-Bacterial Agents; Cytochrome P-450 Enzyme System; Dinoprost; Electrophoresis, Polyacrylamide Gel; Endotoxins; Escherichia coli; In Vitro Techniques; Indomethacin; Intestines; Male; Microsomes, Liver; Mixed Function Oxygenases; Prostaglandins F, Synthetic; Rats; Rats, Inbred Strains; Salicylamides | 1984 |